USP2 and neoplasm: Indeed, USP2 inhibition alone partially induces tumor growth suppression but more strikingly, the combination of USP2 inhibition and PD-1/PD-L1 blockade promote vigorous tumor regression and long-term survival of all tumor-bearing mice.